Verification evidence is still being completed.
PDF / print export
InSphero AG
Schlieren, Switzerland
- Verified lead
- Jan Lichtenberg
- Lead status
- STATUS: VERIFIED APRIL 2026
- Leadership verification
- Chief Executive Officer and Co-Founder
- 2026 technical specialization
- 3D Cell Culture Models, Organ-on-a-Chip, and Drug Safety and Efficacy Testing
- Review cycle
- 24 April 2026
- Full address
- Wagistrasse 27A, 8952 Schlieren, Switzerland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- InSphero press release confirming Jan Lichtenberg as CEO and Co-founder (Entrepreneur of the Year 2015).
- Editorial note
- Schlieren ETH Zurich spin-off pioneering industrial 3D cell culture and organ-on-a-chip platforms for pharma drug development, with US and German subsidiaries.
3D Cell Culture Models, Organ-on-a-Chip, and Drug Safety and Efficacy Testing
ETH Zurich spin-off, Public CEO disclosure, Global pharma customer base
Schlieren ETH Zurich spin-off pioneering industrial 3D cell culture and organ-on-a-chip platforms for pharma drug development, with US and German subsidiaries.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Schlieren, Switzerland
InSphero AG
3D Cell Culture Models, Organ-on-a-Chip, and Drug Safety and Efficacy Testing · Industrial tools and assay manufacturing
Schlieren ETH Zurich spin-off pioneering industrial 3D cell culture and organ-on-a-chip platforms for pharma drug development, with US and German subsidiaries.
- Lead
- Jan Lichtenberg (verified ↗)
- Address
- Wagistrasse 27A, 8952 Schlieren, Switzerland (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 24 Apr 2026 (1mo ago)
- Scale
- Industrial tools and assay manufacturing
- Capabilities
- 3D InSight Microtissue Assays · Scaffold-Free Organ-on-a-Chip Technology · Drug Safety and Efficacy Testing Platforms
- Founded
- 2009
- Headcount
- 51-200
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED APRIL 2026
Jan Lichtenberg
Chief Executive Officer and Co-Founder
Full addressWagistrasse 27A, 8952 Schlieren, Switzerland
Site coordinatesVerification evidence is still being completed.
Review cycle24 April 2026
Physical site source
The Org headquarters listing for InSphero at Wagistrasse 27A, Schlieren.
Open sourceIndustrial tools and assay manufacturing
Schlieren, Switzerland. 3D Cell Culture Models, Organ-on-a-Chip, and Drug Safety and Efficacy Testing. Review completed on 24 Apr 2026.
Swiss quality standards for research tools
ETH Zurich spin-off, Public CEO disclosure, Global pharma customer base
3D Cell Culture Models, Organ-on-a-Chip, and Drug Safety and Efficacy Testing
Schlieren ETH Zurich spin-off pioneering industrial 3D cell culture and organ-on-a-chip platforms for pharma drug development, with US and German subsidiaries.
Editorial note
InSphero is a Schlieren ETH Zurich spin-off founded in 2009, with a named co-founder CEO, 3D InSight microtissue platform, and a global customer base across pharma drug development.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleApril 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
3D InSight Microtissue Assays
Scaffold-Free Organ-on-a-Chip Technology
Drug Safety and Efficacy Testing Platforms
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
3D microtissue production
Organ-on-a-chip platforms
Assay development and characterization
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
24 Apr 2026: Executive identity confirmed via official management disclosure.
24 Apr 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is InSphero AG located?
- InSphero AG operates from Wagistrasse 27A, 8952 Schlieren, Switzerland, Schlieren, Switzerland.
- Who runs InSphero AG?
- InSphero AG is led by Jan Lichtenberg, Chief Executive Officer and Co-Founder. Verified 24 Apr 2026.
- What does InSphero AG do?
- Schlieren ETH Zurich spin-off pioneering industrial 3D cell culture and organ-on-a-chip platforms for pharma drug development, with US and German subsidiaries. Core capabilities: 3D InSight Microtissue Assays, Scaffold-Free Organ-on-a-Chip Technology, Drug Safety and Efficacy Testing Platforms.
Editorial context
Related technical briefs
Briefs that name Schlieren as a covered market or city.